Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience
New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials SINGAPORE, June 2, 2025 /PRNewswire/ -- Medidata, a Dassault Systemes brand and leading...
TuniTuni Opens New Storytelling Kids' Gym in Shek Mun, Hong Kong
HONG KONG, June 2, 2025 /PRNewswire/ -- TuniTuni, the beloved Korean kids' gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan...
Unlocking Trillions: How Data Fuels China- Thailand Business Boom
SHENZHEN, China, June 2, 2025 /PRNewswire/ -- This is a news report from Shenzhen Media Group: "When there's a big volume of products from China, it also helps the Thai economy because people can buy things cheaper than produced in Thailand."...
Dilon Technologies Partners with Australian Allografts as Exclusive Distributor for Navigator 2.0™ Gamma Localization System in Australia
NEWPORT NEWS, Va., June 2, 2025 /PRNewswire/ -- Dilon Technologies is pleased to announce the partnership of Australian Allografts as the exclusive distributor of the Navigator 2.0™ Lymphatic Mapping System in Australia, effective immediately. This...
Peacock 1953 Aircraft Hand Watch: Heritage Meets Horological Innovation in a Tribute to China's Watchmaking Pioneers
SHENZHEN, China, June 2, 2025 /PRNewswire/ -- Peacock Watch today launches the Peacock Perfection Classic 1953 "Aircraft Hand" , a limited-edition timepiece that marries mid-century Chinese watchmaking heritage with 21st-century craftsmanship....
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
SHANGHAI, June 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China...
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
SAN FRANCISCO, and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Hyundai Capital Australia Launches Kia Finance, Expanding its Finance Offerings to All Hyundai Motor Group Vehicles
SEOUL, South Korea, June 2, 2025 /PRNewswire/ -- Hyundai Capital Services announced today that its Australian subsidiary Hyundai Capital Australia Pty. Ltd. ("HCAU" or the "Company") launched Kia Finance and has commenced offering finance solutions...